JP2009528833A5 - - Google Patents

Download PDF

Info

Publication number
JP2009528833A5
JP2009528833A5 JP2008557833A JP2008557833A JP2009528833A5 JP 2009528833 A5 JP2009528833 A5 JP 2009528833A5 JP 2008557833 A JP2008557833 A JP 2008557833A JP 2008557833 A JP2008557833 A JP 2008557833A JP 2009528833 A5 JP2009528833 A5 JP 2009528833A5
Authority
JP
Japan
Prior art keywords
isotope
composition
modified
composition according
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008557833A
Other languages
English (en)
Japanese (ja)
Other versions
JP5844955B2 (ja
JP2009528833A (ja
Filing date
Publication date
Priority claimed from GBGB0604647.8A external-priority patent/GB0604647D0/en
Application filed filed Critical
Publication of JP2009528833A publication Critical patent/JP2009528833A/ja
Publication of JP2009528833A5 publication Critical patent/JP2009528833A5/ja
Application granted granted Critical
Publication of JP5844955B2 publication Critical patent/JP5844955B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008557833A 2006-03-08 2007-03-08 同位体修飾化合物およびフードサプリメントとしてのそれらの使用 Active JP5844955B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0604647.8A GB0604647D0 (en) 2006-03-08 2006-03-08 Stabilized food supplements and their derivatives
GB0604647.8 2006-03-08
PCT/GB2007/050112 WO2007102030A1 (en) 2006-03-08 2007-03-08 Isotopically modified compounds and their use as food supplements

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015045737A Division JP6062470B2 (ja) 2006-03-08 2015-03-09 同位体修飾化合物およびフードサプリメントとしてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2009528833A JP2009528833A (ja) 2009-08-13
JP2009528833A5 true JP2009528833A5 (https=) 2010-04-22
JP5844955B2 JP5844955B2 (ja) 2016-01-20

Family

ID=36241193

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008557833A Active JP5844955B2 (ja) 2006-03-08 2007-03-08 同位体修飾化合物およびフードサプリメントとしてのそれらの使用
JP2015045737A Active JP6062470B2 (ja) 2006-03-08 2015-03-09 同位体修飾化合物およびフードサプリメントとしてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015045737A Active JP6062470B2 (ja) 2006-03-08 2015-03-09 同位体修飾化合物およびフードサプリメントとしてのそれらの使用

Country Status (8)

Country Link
US (5) US8906405B2 (https=)
EP (2) EP3339315B1 (https=)
JP (2) JP5844955B2 (https=)
CA (2) CA2645038C (https=)
DK (1) DK1991068T3 (https=)
ES (1) ES2639395T3 (https=)
GB (1) GB0604647D0 (https=)
WO (1) WO2007102030A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
US8637486B2 (en) 2008-03-14 2014-01-28 Retrotope, Inc. Therapeutic substances that modulate genome methylation
JP2011514361A (ja) * 2008-03-14 2011-05-06 レトロトップ、 インコーポレイテッド 同位体で置換されたリジンを用いたがん治療
US10052299B2 (en) 2009-10-30 2018-08-21 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
ES2676183T3 (es) 2010-07-02 2018-07-17 Ventana Medical Systems, Inc. Detección de dianas usando marcas de masa y espectrometría de masas
KR102112087B1 (ko) 2011-04-26 2020-05-18 레트로토프 인코포레이티드 에너지 프로세싱 손상 장애 및 미토콘드리아 결함
JP6145087B2 (ja) * 2011-04-26 2017-06-07 レトロトップ、 インコーポレイテッドRetrotope, Inc. Pufa酸化関与障害
WO2012148930A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Oxidative retinal diseases
JP6106157B2 (ja) 2011-04-26 2017-03-29 レトロトップ、 インコーポレイテッドRetrotope, Inc. 神経変性障害および筋疾患に関与するpufa
US20150284783A1 (en) * 2012-05-21 2015-10-08 Agena Bioscience, Inc. Methods and compositions for analyzing nucleic acid
AU2015229240B9 (en) 2014-03-13 2019-05-02 Biojiva Llc Optic neuropathy treatment and reduction of steroid-induced oxidative stress with stabilized polyunsaturated substances
EP3950649A1 (en) * 2015-11-23 2022-02-09 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
FR3068135B1 (fr) 2017-06-26 2025-04-04 Ids Group Marquage et identification isotopiques des animaux et vegetaux
EP3773541A4 (en) * 2018-04-04 2022-01-05 Retrotope, Inc. ISOTOPICALLY MODIFIED COMPOSITION AND ITS THERAPEUTIC USES
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
FR3091350B1 (fr) 2019-01-02 2022-03-11 Ids Group Marquage et identification isotopiques des liquides
IL295783B2 (en) 2020-02-21 2026-03-01 Retrotope Inc Processes for isotopic alteration of polyunsaturated fatty acids and their derivatives
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3520872A (en) 1967-03-24 1970-07-21 Upjohn Co Process for labelling purine and pyrimidine containing compounds
DK0455783T3 (da) 1989-11-30 1996-04-01 Croda Int Plc Anvendelse af nervonsyre og langkædede fedtsyrer til behandlingen af demyeliniserende sygdomme
US5244921A (en) 1990-03-21 1993-09-14 Martek Corporation Eicosapentaenoic acids and methods for their production
US5393669A (en) 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
FR2721518B3 (fr) * 1994-06-28 1996-04-12 Gattefosse Ets Sa Compositions cosmétiques, pharmaceutiques, diététiques, vétérinaires contenant de l'eau.
US5578334A (en) 1995-04-07 1996-11-26 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum with fat blends
JPH10291955A (ja) 1997-04-22 1998-11-04 Sagami Chem Res Center 13c標識ドコサヘキサエン酸及びその製造方法
US6111066A (en) * 1997-09-02 2000-08-29 Martek Biosciences Corporation Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains
AU750245B2 (en) 1997-10-08 2002-07-11 Aurinia Phamaceuticals Inc. Deuterated cyclosporine analogs and their use as immunomodulating agents
US6270974B1 (en) * 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
EP1075286A2 (en) 1998-05-06 2001-02-14 Isotechnika, Inc. 13c glucose breath test for the diagnosis of diabetes
IT1304406B1 (it) 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US6503478B2 (en) * 1999-01-13 2003-01-07 Lightouch Medical, Inc. Chemically specific imaging of tissue
JP2000290291A (ja) * 1999-03-31 2000-10-17 Nippon Sanso Corp 安定同位体標識オリゴヌクレオチド及びオリゴヌクレオチド検出方法
GB9929897D0 (en) 1999-12-18 2000-02-09 Slabas Antoni R Improvements in or relating to conjugated fatty acids and related compounds
ATE291910T1 (de) 2001-05-30 2005-04-15 Laxdale Ltd Verwendung von coenzym q (ubiquinone) und eikosapentaensäure (epa) für die behandlung von non-hodgkin's lymphoma und psychiatrischen oder neurologischen erkrankungen
AU2003268693A1 (en) 2002-09-30 2004-04-19 Ajinomoto Co., Inc. Method of producing stable isotope-labeled protein
WO2005005616A2 (en) 2003-07-11 2005-01-20 Egorova-Zachernyuk Tatiana A Compositions and methods for stable isotope labelling of biological compounds
JP2006053100A (ja) 2004-08-13 2006-02-23 Institute Of Physical & Chemical Research 動物の代謝解析方法、ラベル動物の製造方法、ラベル動物、および、動物のnmr測定方法
EP1637163A1 (en) * 2004-09-21 2006-03-22 Andreas Kluge Indicator of therapeutic compliance
BRPI0516803A (pt) 2004-11-19 2008-09-23 Martek Biosciences Corp oxilipinas de ácidos graxos polinsaturados de cadeia longa e métodos de produção e uso dos mesmos
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
US20080234197A1 (en) 2007-03-19 2008-09-25 Undurti N Das Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF)
ES2700141T3 (es) 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
US20090069354A1 (en) 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched gemcitabine
US8637486B2 (en) 2008-03-14 2014-01-28 Retrotope, Inc. Therapeutic substances that modulate genome methylation
JP2011514361A (ja) 2008-03-14 2011-05-06 レトロトップ、 インコーポレイテッド 同位体で置換されたリジンを用いたがん治療

Similar Documents

Publication Publication Date Title
JP2009528833A5 (https=)
Anderson et al. Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy
Furmaniak et al. Edible cyanobacterial genus Arthrospira: Actual state of the art in cultivation methods, genetics, and application in medicine
CN102450618B (zh) 一种黑蒜的制作方法
TR201908522T4 (tr) Kan lipidi düşürücü maddeler olarak keton gövdeleri ve keton gövde esterleri.
WO2017208217A2 (en) C5 ketone compositions, and related methods, for therapeutic and performance supplementation
WO2010146568A3 (en) Bifidobacteria for treating diabetes and related conditions
NZ627238A (en) Stable pharmaceutical composition comprising ethyl eicosapentaenoate
CN114867863A (zh) 基于含氮天然物质的发酵的一氧化氮代谢组的固定化及稳定化方法
CN104223107A (zh) 一种护肝解酒排毒的保健品
Marchionni et al. The role of'modified Mediterranean diet'and quantum therapy in Alzheimer's disease primary prevention
JP5547486B2 (ja) セサミン類とアラキドン酸類を含有する組成物
Chechet et al. The effect of complex application of symbiotic and biocidal preparations on the metabolic status of broiler chickens' blood
CN101062025A (zh) 用于减肥、降脂、降糖、降压、防治骨质疏松的复方制剂
CN108391816A (zh) 一种抗氧化保健胶囊的生产方法
JP2008266203A (ja) 活性酸素種消去酵素群の活性を向上させる方法
Cheng et al. Effects of dietary algal docosahexaenoic acid oil supplementation on fatty acid deposition and gene expression in laying Leghorn hens
CN118684638A (zh) 一种左旋肉碱维生素c加合物的制备方法及加合物与应用
JP7069531B2 (ja) ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル
CN101589745B (zh) 一种脱毒杏仁油的生产方法
TW201705951A (zh) 哺乳類sirt1的活化劑
JP2013047197A (ja) スピルリナ組成物
Asgharpour et al. The Effect of four Weeks of Continuous Aerobic Training and Starvation on the Expression of Gene Pink1 and Bnibp3 in liver Tissue, liver Enzymes and lipid profile in Wistar Fatty Model Rats
JP2004298161A (ja) ホヤエキスの抽出方法及び抽出成分を含有する健康食品
CN108434358B (zh) 一种具有神经保护作用的营养组合物及其制备方法和应用